Walvax Biotechnology Co., Ltd. (SHE: 300142)

Walvax Biotechnology Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 8, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	23,830	37,601	64,274	89,423	59,516	49,874
Market Cap Growth	-57.08%	-41.50%	-28.12%	50.25%	19.33%	69.84%
Enterprise Value	23,378	36,117	62,959	88,584	58,587	48,620
Last Close Price	14.90	23.49	40.15	56.11	38.47	32.35
PE Ratio	176.95	89.63	88.35	206.36	59.79	350.50
PS Ratio	7.05	9.14	12.64	25.82	20.25	44.48
PB Ratio	2.51	3.30	5.85	8.94	7.58	8.80
P/FCF Ratio	454.24	199.73	582.65	-224.56	-203.17	-172.10
P/OCF Ratio	21.67	33.16	53.50	126.79	521.18	804.21
EV/Sales Ratio	6.92	8.78	12.38	25.58	19.93	43.36
EV/EBITDA Ratio	41.19	35.24	44.27	95.49	51.04	195.96
EV/EBIT Ratio	102.44	49.15	53.63	111.82	57.22	283.54
EV/FCF Ratio	445.62	191.86	570.72	-222.46	-200.00	-167.77
Debt / Equity Ratio	0.06	0.07	0.04	0.03	0.01	-
Debt / EBITDA Ratio	1.32	0.77	0.32	0.34	0.03	-
Debt / FCF Ratio	14.28	4.28	4.19	-0.79	-0.14	-
Asset Turnover	0.22	0.27	0.35	0.30	0.35	0.16
Inventory Turnover	0.77	0.74	0.72	0.59	1.02	0.86
Quick Ratio	2.52	2.38	2.24	2.07	3.00	2.86
Current Ratio	2.94	2.73	2.55	2.37	3.36	3.16
Return on Equity (ROE)	1.79%	4.57%	8.94%	6.74%	17.93%	3.55%
Return on Assets (ROA)	0.93%	2.97%	5.06%	4.25%	7.68%	1.50%
Return on Capital (ROIC)	1.17%	3.88%	6.74%	5.44%	9.44%	1.91%
Earnings Yield	0.57%	1.12%	1.13%	0.48%	1.69%	0.28%
FCF Yield	0.22%	0.50%	0.17%	-0.45%	-0.49%	-0.58%
Dividend Yield	0.06%	0.04%	0.02%	0.05%	0.18%	-
Payout Ratio	17.76%	4.76%	6.88%	19.48%	3.16%	48.38%
Buyback Yield / Dilution	0.17%	0.21%	-1.93%	-0.90%	-1.37%	-0.05%
Total Shareholder Return	0.23%	0.26%	-1.91%	-0.85%	-1.18%	-0.05%

Source: S&P Capital IQ. Standard template. Financial Sources.